标签： 财经频道 财经资讯 人民财讯9月30日电，润达医疗(603108)9月30日公告，公司股东朱文怡及公司董事、高级管理人员 刘辉拟通过大宗交易或集中竞价交易方式合计减持不超2.99%公司股份。朱文怡及刘辉系母子关系。 (资料图片) ...

智通财经APP讯，润达医疗(603108.SH)发布公告，公司股东朱文怡及刘辉拟在公告之日起15个交易日 后的三个月内通过大宗交易或集中竞价交易方式减持股份，拟合计减持不超2.99%公司股份。 ...

Core Viewpoint - RunDa Medical (603108.SH) announced that shareholders Zhu Wenyi and Liu Hui plan to reduce their holdings by up to 2.99% of the company's shares within three months after 15 trading days from the announcement date [1] Summary by Relevant Sections - Shareholder Actions - Shareholders Zhu Wenyi and Liu Hui intend to reduce their stakes in the company [1] - The reduction will occur through block trades or centralized bidding [1] - The total shares to be reduced amount to no more than 2.99% of the company's total shares [1]

Core Viewpoint - The company, RunDa Medical, announced that shareholders Zhu Wenyi and senior management member Liu Hui plan to reduce their holdings by up to 2.99% of the company's shares through block trading or centralized bidding [1] Group 1 - Shareholders Zhu Wenyi and Liu Hui are related as mother and son [1] - The reduction in shareholding is significant as it involves a combined total of up to 2.99% of the company's shares [1]

证券代码：603108 证券简称：润达医疗 公告编号：临 2025-052 转债代码：113588 转债简称：润达转债 上海润达医疗科技股份有限公司 股东及董监高减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 大股东及董监高持股的基本情况 截至本公告披露日：股东朱文怡持有上海润达医疗科技股份有限公司（以下 简称"公司"、"润达医疗"）股份共计 31,518,408 股，占公司总股本 5.22%。公 司董事、高级管理人员刘辉持有公司股份共计 31,528,771 股，占公司总股本 5.22%。 减持计划的主要内容 公司股东朱文怡及刘辉拟在本公告之日起 15 个交易日后的三个月内通过大 宗交易或集中竞价交易方式减持股份。 | 股东 | 减持数量 | | 占公司总股份数 | | --- | --- | --- | --- | | 朱文怡 | 不超过：10,540,000 | 股 | 不超过：1.75% | | 刘辉 | 不超过：7,460,000 | 股 | 不超过：1.24% | 股东后 ...

Core Viewpoint - RunDa Medical (603108.SH) announced that shareholders Zhu Wenyi and Liu Hui plan to reduce their holdings through block trades or centralized bidding within three months after 15 trading days from the announcement date [1] Summary by Relevant Categories Shareholder Actions - Zhu Wenyi intends to reduce holdings by no more than 10.54 million shares, which accounts for up to 1.75% of the total shares [1] - Liu Hui plans to reduce holdings by no more than 7.46 million shares, representing up to 1.24% of the total shares [1]

Core Viewpoint - Shanghai RunDa Medical Technology Co., Ltd. announced a share reduction plan by shareholders and executives, indicating personal financial needs as the reason for the reduction [1] Shareholder and Executive Holdings - Shareholder Zhu Wenyiyi holds 31,518,408 shares, accounting for 5.22% of the total share capital [1] - Executive Liu Hui holds 31,528,771 shares, also accounting for 5.22% of the total share capital, and they are in a mother-son relationship [1] Reduction Plan Details - Zhu Wenyiyi plans to reduce holdings by no more than 10,540,000 shares (up to 1.75%) [1] - Liu Hui plans to reduce holdings by no more than 7,460,000 shares (up to 1.24%) [1] - The reduction will occur within three months starting from 15 trading days after the announcement, specifically from October 30, 2025, to January 29, 2026 [1] Uncertainty and Control - The number of shares to be reduced will be adjusted according to ex-rights and ex-dividend matters, indicating some uncertainty in the plan [1] - The share reduction will not lead to a change in the company's control [1]

Group 1 - The core point of the article is that RunDa Medical (603108.SH) announced that shareholders Zhu Wenyi and Liu Hui plan to reduce their holdings of shares within three months through block trading or centralized bidding after 15 trading days from the announcement date [1] - Zhu Wenyi intends to reduce holdings by no more than 10.54 million shares, which accounts for up to 1.75% of the total shares [1] - Liu Hui plans to reduce holdings by no more than 7.46 million shares, representing up to 1.24% of the total shares [1]

Core Points - A social media post reported that a job candidate was dismissed by Deli Group on the day of onboarding due to a walking disability, which sparked public attention [1] - Deli Group's CEO, Chen Xueqiang, publicly apologized and stated that the incident does not align with the company's values and commitment to human care [1] - The affected individual declined a follow-up invitation from Deli Group for re-employment, citing concerns over public scrutiny and expressing a desire for fair treatment of disabled individuals in the workplace [2] Company Overview - Deli Group was founded in 1981 and is located in Ninghai County, Ningbo City, Zhejiang Province, China [2] - The company’s product lines include office and student stationery, office equipment, office supplies, and office paper products [2]

Core Insights - On September 25, RunDa Medical's stock rose by 1.49% with a trading volume of 279 million yuan [1] - The company experienced a net financing outflow of 173,800 yuan on the same day, with a total financing and securities balance of 566 million yuan [1] - As of June 30, 2025, RunDa Medical reported a revenue of 3.47 billion yuan, a year-on-year decrease of 16.08%, and a net profit attributable to shareholders of -121 million yuan, a significant decline of 232.14% [2] Financing and Securities - On September 25, the financing buy-in amount for RunDa Medical was 48.17 million yuan, with a current financing balance of 564 million yuan, representing 5.71% of the market capitalization [1] - The company’s financing balance is below the 10th percentile level over the past year, indicating a low position [1] - In terms of securities lending, 1,300 shares were repaid and 2,000 shares were sold on September 25, with a selling amount of 32,700 yuan [1] Shareholder and Dividend Information - As of June 30, 2025, the number of shareholders for RunDa Medical was 65,500, a decrease of 13.82% from the previous period [2] - The company has distributed a total of 373 million yuan in dividends since its A-share listing, with 165 million yuan distributed in the last three years [3] - New institutional shareholders include招商优势企业混合A and 南方中证1000ETF, while 香港中央结算有限公司 has exited the top ten shareholders list [3]